ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO336

Eliciting Patient and Caregiver Priority Outcomes in CKD: An International Nominal Group Study

Session Information

Category: CKD (Non-Dialysis)

  • 2102 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Gutman, Talia M., University of Sydney, Sydney, New South Wales, Australia
  • Craig, Jonathan C., Flinders University, Adelaide, South Australia, Australia
  • Scholes-Robertson, Nicole Jane, University of Sydney, Sydney, New South Wales, Australia
  • Tong, Allison, University of Sydney, Sydney, New South Wales, Australia

Group or Team Name

  • Standardised Outcomes in Nephrology (SONG) Initiative - Chronic Kidney Disease
Background

Patients with chronic kidney disease (CKD) are at an increased risk of premature death and cardiovascular disease, and experience symptoms that impair quality of life. We aimed to identify patient and caregiver priority outcomes in CKD.

Methods

Patients with CKD (stages 1-5, dialysis or transplant) and caregivers were purposively sampled from seven centers (10 groups) across United States, Australia, and United Kingdom. Participants identified outcomes that were important in CKD Stages 1-5 (prior to commencing kidney replacement therapy (KRT)) and individually ranked their top 10 from most important to least important. A relative importance score (0 to 1) was calculated for each outcome based on frequency and rank.

Results

In total, 54 patients and 13 caregivers aged over 18 years participated, with 36 outcomes identified. The five top ranked outcomes for patients were: kidney function (importance score = 0.42; 95%CI 0.31-0.53), end stage kidney disease (0.29; 0.21-0.38), fatigue (0.26; 0.19-0.35), mortality (0.25; 0.17-0.35) and life participation (0.20; 0.14-0.27). For caregivers the top five outcomes were: life participation (0.38; 0.19 -0.59), kidney function (0.37; 0.18-0.59), mortality (0.23; 0.07-0.45), fatigue (0.21; 0.10-0.37) and anxiety (0.20; 0.08-0.35). Blood pressure, cognition and depression were consistently ranked in the top ten outcomes across role (patient/caregiver), country and stage of CKD (CKD vs KRT).

Conclusion

Patients and caregivers gave highest priority to kidney health, mortality, fatigue, life participation, and mental wellbeing. Consistent reporting of these outcomes in research can inform shared decision-making based on outcomes that are relevant and critical to patients and caregivers in CKD.

Figure 1. Top ranked outcomes by role